RET inhibition in novel patient-derived models of RET fusion- positive lung adenocarcinoma reveals a role for MYC upregulation
Multi-kinase RET inhibitors, such as cabozantinib and RXDX-105, are active in lung cancer patients with RET fusions; however, the overall response rates to these two drugs are unsatisfactory compared to other targeted therapy paradigms. Moreover, these inhibitors may have different efficacies agains...
Saved in:
Main Authors: | Takuo Hayashi (Author), Igor Odintsov (Author), Roger S. Smith (Author), Kota Ishizawa (Author), Allan J. W. Liu (Author), Lukas Delasos (Author), Christopher Kurzatkowski (Author), Huichun Tai (Author), Eric Gladstone (Author), Morana Vojnic (Author), Shinji Kohsaka (Author), Ken Suzawa (Author), Zebing Liu (Author), Siddharth Kunte (Author), Marissa S. Mattar (Author), Inna Khodos (Author), Monika A. Davare (Author), Alexander Drilon (Author), Emily Cheng (Author), Elisa de Stanchina (Author), Marc Ladanyi (Author), Romel Somwar (Author) |
---|---|
Format: | Book |
Published: |
The Company of Biologists,
2021-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ret-dependent and Ret-independent mechanisms of Gfl-induced sensitization
by: Meadows Rena M, et al.
Published: (2011) -
Clinical development of RET inhibitors in RET-rearranged non-small cell lung cancer: update
by: Luis Mendoza
Published: (2018) -
Novel patient-derived models of desmoplastic small round cell tumor confirm a targetable dependency on ERBB signaling
by: Roger S. Smith, et al.
Published: (2022) -
Aberrant SOX10 and RET expressions in patients with Hirschsprung disease
by: Gunadi, et al.
Published: (2024) -
Multiple endocrine neoplasias type 2B and RET proto-oncogene
by: Martucciello Giuseppe, et al.
Published: (2012)